Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 750-755

  Martínez Turrillas, Rebeca ^a,b   Del Río, Joaquín ^a,b   Frechilla, Diana ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

AMPA receptors; Antidepressants; Glutamate; Hippocampus; Mood disorders; Synaptic plasticity

Indexed keywords

AMPA RECEPTOR; ANTIDEPRESSANT AGENT; DESIPRAMINE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; PAROXETINE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN RAB4A; PROTEIN SAP97; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; IMMUNOPRECIPITATION; MALE; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SYNAPTIC MEMBRANE; WESTERN BLOTTING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DESIPRAMINE; HIPPOCAMPUS; MALE; NEURONAL PLASTICITY; PAROXETINE; PROTEIN SUBUNITS; PROTEIN TRANSPORT; RATS; RATS, WISTAR; RECEPTORS, AMPA; SYNAPSES;

RATTUS;

EID: 33845996501     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.078     Document Type: Article

References (32)

1. Skolnick P. Antidepressants for the new millennium. Eur. J. Pharmacol. 375 (1999) 31-40
2. Del Río J., and Frechilla D. Glutamate and depression. In: Schmidt W.J., and Reith M.E.A. (Eds). Dopamine and Glutamate in Psychiatric Disorders (2005), Humana Press, N.J. Totowa 215-234
3. Alt A., Nisenbaum E.S., Bleakman D., and Witkin J.M. A role for AMPA receptors in mood disorders. Biochem. Pharmacol. 71 (2006) 1273-1288
4. Li X., Tizzano J.P., Griffey K., Clay M., Lindstrom T., and Skolnick P. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40 (2001) 1028-1033
5. Svenningsson P., Tzavara E.T., Witkin J.M., Fienberg A.A., Nomikos G.G., and Greengard P. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioural effects of fluoxetine (Prozac). Proc. Natl. Acad. Sci. USA 99 (2002) 3182-3187
6. Martinez-Turrillas R., Frechilla D., and Del Río J. Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43 (2002) 1230-1237
7. Du J., Gray N.A., Falke C.A., Chen W., Yuan P., Szabo S.T., et al. Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J. Neurosci. 24 (2004) 6578-6589
8. Barbon A., Popoli M., La Via L., Moraschi S., Vallini I., Tardito D., et al. Regulation of editing and expression of glutamate (α-amino-propionic-acid (AMPA)/kainate receptors by antidepressants drugs. Biol. Psychiatry 59 (2006) 713-720
9. Martinez-Turrillas R., Del Río J., and Frechilla D. Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49 (2005) 1178-1188
10. Gerges N.Z., Backos D.S., and Esteban J.A. Local control of AMPA receptor trafficking at the postsynaptic terminal by a small GTPase of the Rab family. J. Biol. Chem. 279 (2004) 43870-43878
11. Park M., Penick E.C., Edwards J.G., Kauer J.A., and Ehlers M.D. Recycling endosomes supply AMPA receptors for LTP. Science 305 (2004) 1972-1975
12. Sheng M., and Lee S.H. AMPA receptor trafficking and the control of synaptic transmission. Cell 105 (2001) 825-828
13. Hayashi Y., Shi S.H., Esteban J.A., Piccini A., Poncer J.C., and Malinow R. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287 (2000) 2262-2267
14. Oh M.C., Derkach V.A., Guire E.S., and Soderling T.R. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J. Biol. Chem. 281 (2006) 752-758
15. Esteban J.A. AMPA receptor trafficking: a road map for synaptic plasticity. Mol. Interv. 3 (2003) 375-385
16. Leonard A.S., Davare M.A., Horne M.C., Garner C.C., and Hell J.W. SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J. Biol. Chem. 273 (1998) 19518-19524
17. Chen L., Chetkovich D.M., Petralia R.S., Sweeney N.T., Kawasaki Y., Wenthold R.J., et al. Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. Nature 408 (2000) 936-943
18. Schnell E E., Sizemore M., Karimzadegan S., Chen Lu., Bredt D.S., and Nicoll R.A. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc. Natl. Acad. Sci. USA 99 (2002) 13902-13907
19. Kim C.H., Chung H.J., Lee H.K., and Huganir R.L. Interaction of the AMPA receptor subunit GluR2/3 with PDZ domains regulates hippocampal long-term depression. Proc. Natl. Acad. Sci. USA 98 (2001) 11725-11730
20. Song I., Kamboj S., Xia J., Dong H., Liao D., and Huganir R.L. Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron 21 (1998) 393-400
21. Noel J., Ralph G.S., Pickard L., Williams J., Molnar E., Uney J.B., et al. Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism. Neuron 23 (1999) 365-376
22. Dunah A.W., Wang Y., Yasuda R.P., Kameyama K., Huganir R.L., Wolfe B.B., et al. Alterations in subunit expression, composition and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol. 57 (2000) 342-352
23. Malinow R., and Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25 (2002) 103-126
24. Olkkonen V.M., and Stenmark H. Role of Rab GTPases in membrane traffic. Int. Rev. Cytol. 176 (1997) 1-85
25. Andriamampandry C., Muller C., Schmidt-Mutter C., Gobaille S., Spedding M., Aunis D., and Maitre M. Mss4 gene is up-regulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol. Pharmacol. 62 (2002) 1332-1338
26. Burton J.L., Burns M.E., Gatti E., Augustine G.J., and De Camilli P. Specific interactions of Mss4 with members of the Rab GTPase subfamily. EMBO J. 13 (1994) 5547-5558
27. Sans N., Racca C., Petralia R.S., Wang Y.X., McCAllum J., and Wenthold R.J. Synapse-associated protein 97 selectively associates with a subset of AMPA receptors early in their biosynthetic pathway. J. Neurosci. 21 (2001) 7506-7516
28. Gardoni F., Mauceri D., Fiorentini C., Bellone C., Missale C., Cattabeni F., and Di Luca M. CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction. J. Biol. Chem. 278 (2003) 44745-44752
29. J. Du, K. Suzuki, Y. Wei, Y. Wang, R. Blumenthal, Z. Chen, et al, The anticonvulsants Lamotrigine, Riluzole, and Valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders, Neuropsychopharmacology, 2006 [Epub August 16].
30. Nicoll R.A., Tomita S., and Bredt D.S. Auxiliary subunits assist AMPA-type glutamate receptors. Science 311 (2006) 1253-1256
31. Shi S.H., Hayashi Y., Esteban J.A., and Malinow R. Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105 (2001) 331-334
32. Braithwaite S.P., Xia H., and Malenka R.C. Differential roles for NSF and GRIP/ABP in AMPA receptor cycling. Proc. Natl. Acad. Sci. USA 99 (2002) 7096-7101